30 Participants NeededMy employer runs this trial

Propylene Glycol Exposure for Healthy Subjects

EL
Overseen ByErin Lewis, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to determine the translation of propylene glycol (PG) exposure in beverages to circulating PG levels to better understand the margin of safety in healthy participants. The main question it aims to answer is what is the maximum concentration (Cmax) of propylene glycol (PG) in serum following consumption of one, two, or three PG-containing beverages? Participants will be asked to:

* Consume 1x, 2x, and 3x 12oz of PG-containing beverage

* Have their blood drawn

* Complete urine pregnancy testing if of childbearing potential

* Complete a study diary and record their food and beverage consumption

* Have their vital signs and oxygen measurements taken

Who Is on the Research Team?

DC

David Crowley

Principal Investigator

KGK Science Inc.

Are You a Good Fit for This Trial?

This trial is for healthy adults age 18 or older with a BMI between 18.5 and 29.9. Women must not be pregnant and must use reliable birth control if of childbearing potential. Participants need to avoid alcohol and strenuous exercise before study visits.

Inclusion Criteria

I am 18 years old or older.
2. Body Mass Index (BMI) between 18.5 to 29.9 kg/m2
I am not heterosexual and will use contraception if I plan to have heterosexual partners.
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants consume 1x, 2x, and 3x 12oz of PG-containing beverage and undergo various assessments including blood draws and vital sign measurements

12 days
Visits 2, 4, and 6 for beverage consumption

Follow-up

Participants are monitored for safety and effectiveness after treatment, including clinically relevant changes in various health parameters

24 hours post-dose

What Are the Treatments Tested in This Trial?

Trial Overview

The study tests how much propylene glycol (PG) enters the bloodstream after drinking one, two, or three PG-containing beverages. Blood samples are taken at different times to measure PG levels.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Propylene glycol-containing beverageExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

American Beverage Association

Lead Sponsor

Trials
2
Recruited
690+

KGK Science Inc.

Industry Sponsor

Trials
82
Recruited
6,400+

Najla Guthrie

KGK Science Inc.

Chief Executive Officer since 1997

Research career at the Centre for Human Nutrition, University of Western Ontario

Dr. Bibiane Zakaria

KGK Science Inc.

Chief Medical Officer since 2023

MD from an unspecified institution